+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Brand (Magmaris, Magnitude, MeRes100, DESolve, Others), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 77 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899654
Description Jump to:
The global bioresorbable coronary stents market size is expected to reach USD 442.9 million by 2030, expanding at a CAGR of 15.3% from 2023 to 2030. better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices. Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Bioresorbable Coronary Stents Market Report Highlights

  • Asia Pacific is anticipated to register the fastest CAGR of 16.8% over the forecast period.
  • Absorb BVS, among the key brands, engendered the highest sales revenue in 2022, while Absorb 2nd generation device will supersede the sales of its rival devices toward the end of the forecast period.
  • The U.S. trails behind with low prominence in this market. The downfall of Abbott’s Absorb BVS, coupled with a lack of other bioresorbable stents seeking FDA clearance to capitalize on the opportunity, has resulted in low immediate prospects for bioresorbable coronary stents in this region
  • Key players in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation, REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
  • Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Brand
1.1.2. Region
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Brand outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Bioresorbable Coronary Stents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Bioresorbable Coronary Stents Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Bioresorbable Coronary Stents Market: Brand Estimates & Trend Analysis
4.1. Bioresorbable Coronary Stents Market: Key Takeaways
4.2. Bioresorbable Coronary Stents Market: Brand Movement & Market Share Analysis, 2022 & 2030
4.3. Magnitude
4.3.1. Magnitude market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Magmaris
4.4.1. Magmaris market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. MeRes100
4.5.1. MeRes100 market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. DESolve
4.6.1. DESolve market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Bioresorbable Coronary Stents Market by Region: Key Takeaways
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Boston Scientific Corporation
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Medtronic
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Cordis
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Biotronik
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Meril Life Sciences Pvt. Ltd.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Abbott
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Elixir Medical
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. REVA Medical, LLC
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Arterial Remodeling Technologies SA
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 3 North America bioresorbable coronary stents market, by region, 2018-2030 (USD Million)
Table 4 U.S. bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 5 Canada bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 6 Europe bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 7 Europe bioresorbable coronary stents market, by region, 2018-2030 (USD Million)
Table 8 Germany bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 9 UK bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 10 France bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 11 Italy bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 12 Spain bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 13 Sweden bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 14 Norway bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 15 Denmark bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 16 Asia Pacific bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 17 Asia Pacific bioresorbable coronary stents market, by region, 2018-2030 (USD Million)
Table 18 China bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 19 Japan bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 20 India bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 21 Australia bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 22 Thailand bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 23 South Korea bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 24 Latin America bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 25 Latin America bioresorbable coronary stents market, by region, 2018-2030 (USD Million)
Table 26 Brazil bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 27 Mexico bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 28 Argentina bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 29 Middle East and Africa bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 30 Middle East and Africa bioresorbable coronary stents market, by region, 2018-2030 (USD Million)
Table 31 South Africa bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 32 Saudi Arabia bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 33 UAE bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
Table 34 Kuwait bioresorbable coronary stents market, by brand, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Bioresorbable coronary stents: Market outlook
Fig. 8 Bioresorbable coronary stents: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Bioresorbable coronary stents market driver impact
Fig. 14 Bioresorbable coronary stents market restraint impact
Fig. 15 Bioresorbable coronary stents market strategic initiatives analysis
Fig. 16 Bioresorbable coronary stents market: Brand movement analysis
Fig. 17 Bioresorbable coronary stents market: Brand outlook and key takeaways
Fig. 18 Magmaris market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Magnitude market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 MeRes100 market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 DESolve market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 Global bioresorbable coronary stents market: Regional movement analysis
Fig. 24 Global bioresorbable coronary stents market: Regional outlook and key takeaways
Fig. 25 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Boston Scientific Corporation
  • Medtronic
  • Cordis
  • Biotronik
  • Meril Life Sciences Pvt. Ltd.
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Arterial Remodeling Technologies SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages77
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 140.25 Million
Forecasted Market Value ( USD ) by 2030 $ 442.9 Million
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Coronary Stents Market by Product, Material, Deployment, End-User - Global Forecast 2025-2030 - Product Image

Coronary Stents Market by Product, Material, Deployment, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Bioresorbable Coronary Stent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Bioresorbable Coronary Stent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
Global Coronary Stents Market - Focused Insights 2024-2029 - Product Image

Global Coronary Stents Market - Focused Insights 2024-2029

  • Report
  • 144 Pages
  • Global
From
Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Bioresorbable Coronary Stents Market

Bioresorbable coronary stents are a type of cardiovascular device used to treat coronary artery disease. They are designed to be implanted in the coronary artery to open a blocked artery and restore blood flow. Unlike traditional metal stents, bioresorbable stents are made of biodegradable polymers that dissolve over time, allowing the artery to return to its natural state. This technology has the potential to reduce the risk of long-term complications associated with metal stents, such as restenosis and late stent thrombosis. Bioresorbable coronary stents are still in the early stages of development, but the market is expected to grow rapidly in the coming years. Companies are investing heavily in research and development to improve the safety and efficacy of these devices. Some of the major players in the bioresorbable coronary stents market include Abbott, Biotronik, Boston Scientific, Elixir Medical, and Medtronic. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.